Category: Latest News
-

Dow Jones, S&P, Nasdaq, Futures Tread Water as Markets Weigh Data, Trump-Fed Tensions, and Earnings
U.S. stock futures were flat in early Thursday trading, signaling a muted open as investors digest a wave of mixed economic data, fresh earnings results, and heightened political drama involving President Donald Trump and Federal Reserve Chair Jerome Powell. After a choppy session on Wednesday that ended with modest gains across major indexes, traders appear…
-

U.S. Jobless Claims Dip Unexpectedly as Retail Sales Surge in June
In a positive surprise for the labor market, new U.S. unemployment claims declined during the week ending July 12, according to fresh data from the Labor Department released Thursday. Initial applications for unemployment benefits dropped by 7,000 to 221,000, down from a revised 228,000 the prior week. This defied economist forecasts, which had anticipated an…
-

Archer-Daniels-Midland shares tumble following Trump’s Coca-Cola sugar announcement
Archer-Daniels-Midland (NYSE:ADM) saw its stock drop as much as 5.6% in premarket trading on Thursday after President Trump announced that Coca-Cola (NYSE: KO) plans to use “real cane sugar” in its soda products sold in the U.S. This potential move away from high-fructose corn syrup could have a significant impact on ADM, a leading processor…
-

ManpowerGroup reports Q2 loss amid goodwill impairment charges
ManpowerGroup (NYSE:MAN) posted a net loss for the second quarter on Wednesday, weighed down by an $89 million non-cash goodwill impairment charge, despite steady revenue performance. For the quarter ending June 30, 2025, the company reported a loss of $1.44 per share, compared to earnings of $1.24 per diluted share in the same period last…
-

Clearside Biomedical shares dip after announcing exploration of strategic alternatives
Clearside Biomedical, Inc. (NASDAQ:CLSD) saw its stock decline 0.7% Thursday following the company’s announcement that it is exploring strategic alternatives to advance its proprietary Suprachoroidal Space (SCS) delivery platform and ophthalmology pipeline. The biopharma firm has engaged Piper Sandler to assist with the evaluation process, which may involve asset sales, licensing deals, monetization, divestitures, or…
-

Abbott’s Q2 revenue surpasses expectations despite share decline
Abbott Laboratories (NYSE:ABT) reported second-quarter earnings that modestly beat analyst forecasts, yet the company’s shares dropped 2.5% following the announcement. The healthcare leader posted adjusted earnings per share of $1.26 for the quarter, slightly above the consensus estimate of $1.25. Revenue reached $11.42 billion, well ahead of the $11.07 billion anticipated by analysts, marking a…
-

Micron shares dip following Goldman Sachs downgrade of SK Hynix
Micron Technology (NASDAQ:MU) saw its stock drop 3.9% in pre-market trading on Thursday after Goldman Sachs downgraded SK Hynix (KS:000660), a major competitor in the memory chip industry. This downgrade sent waves through the semiconductor sector. Goldman Sachs analyst Giuni Lee lowered SK Hynix’s rating from Buy to Neutral, resulting in a 9% decline in…
-

Travelers surpasses expectations with strong Q2 results
Travelers Companies, Inc. (NYSE:TRV) announced robust second-quarter 2025 core income of $1.5 billion, or $6.51 per diluted share, far exceeding analyst forecasts of $3.60 per share. Revenue for the period totaled $12.12 billion, beating the consensus estimate of $11.62 billion. Following the announcement, the insurance giant’s shares saw a slight decline of 0.23% in pre-market…
-

U.S. Bancorp stock slips despite earnings beat as revenue disappoints
U.S. Bancorp (NYSE:USB) reported stronger-than-expected second-quarter earnings on Thursday, but the stock slid 2.69% in pre-market trading as overall revenue came in shy of analyst forecasts. The Minneapolis-based lender posted earnings per share of $1.11 for the quarter, beating the consensus estimate of $1.07. However, total revenue came in at $6.96 billion, narrowly missing the…
-

Texas Capital Bancshares stock jumps nearly 3% after blowout Q2 earnings
Texas Capital Bancshares (NASDAQ:TCBI) delivered second-quarter results on Thursday that easily topped Wall Street forecasts, thanks to strong loan expansion and improved profitability from interest income. The report sent shares up 2.74% in pre-market trading. The Dallas-based bank reported adjusted earnings per share of $1.63 for Q2 2025, outpacing the consensus estimate of $1.28. Total…